Article

Case analysis of a patient with NTRK gene fusion-positive colorectal cancer presenting with short-lived response

2026-07-17

Abstract excerpt

<title>Abstract</title> <p> <bold>Introduction:</bold> Neurotrophic tyrosine receptor kinase (NTRK) gene fusions are rare oncogenic driver mutations in solid tumours; however, their incidence in colorectal cancer is extremely low (approximately 0.5%–2%), and they are rarely targeted in clinical practice. <bold>Case Report:</bold> We report a case of a female patient with advanced colorectal cancer who was RAS...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: dd0374dd-d7bd-5fe0-9642-eeb0dae75e95
DOI: 10.21203/rs.3.rs-10023779/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Case analysis of a patient with NTRK gene fusion-positive colorectal cancer presenting with short-lived responseDOI 10.21203/rs.3.rs-10023779/v1Read

Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinibSemantic proximity Read

Evaluating larotrectinib for the treatment of advanced solid tumors harboring an NTRK gene fusionSemantic proximity Read

Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal CancerSemantic proximity Read

NTRK fusion positive colorectal cancer is a unique subset of CRC with high TMB and microsatellite instability.Semantic proximity Read

A review of NTRK fusions in cancerSemantic proximity Read

Larotrectinib, a highly selective tropomyosin receptor kinase (TRK) inhibitor for the treatment of TRK fusion cancerSemantic proximity Read

Clinicopathologic and molecular spectrum of gastrointestinal stromal tumor (GIST) with NTRK fusion and marked response to Larotrectinib in GIST with NTRK fusion: a case reportSemantic proximity Read

Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in ChinaSemantic proximity Read

Antitumor activity of larotrectinib in tumors harboring NTRK gene fusions: a short review on the current evidenceSemantic proximity Read

China special issue on gastrointestinal tumors-NTRK fusion in a large real-world population and clinical utility of circulating tumor DNA genotyping to guide TRK inhibitor treatment.Semantic proximity Read

A novel NCOR2-NTRK1 fusion detected in a patient of lung adenocarcinoma and response to larotrectinib: a case report.Semantic proximity Read

Safety of current treatment options for NTRK fusion-positive cancersSemantic proximity Read